Ticker Details
Apogee Therapeutics, Inc.
IPO Date:	July 14, 2023
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$6.81B
Activated in VL:	False

Average Daily Range
Avg Daily Range:	$1.41 | 3.16%
Avg Daily Range (30 D):	$2.50 | 2.97%
Avg Daily Range (90 D):	$2.07 | 2.66%

Institutional Daily Volume
Avg Daily Volume:	.51M
Avg Daily Volume (30 D):	.78M
Avg Daily Volume (90 D):	.75M

Trade Size
Avg Trade Size (Sh.):	55
Avg Trade Size (Sh.) (30 D):	54
Avg Trade Size (Sh.) (90 D):	54

Institutional Trades
Total Institutional Trades:	339
Avg Institutional Trade:	$10.6M
Avg Institutional Trade (30 D):	$10.6M
Avg Institutional Trade (90 D):	$10.6M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	339

Market Closing Trades
Avg Closing Trade:	$76.62M
Avg Closing Trade (30 D):	$76.62M
Avg Closing Trade (90 D):	$76.62M
Avg Closing Volume:	578.04K

News

Jul 25, 2026 @ 2:15 PM Why Wall Street Can't Get Enough of This Dividend ... Source: Reuben Gregg Brewer

Jul 21, 2026 @ 10:30 PM 3 Reasons to Buy AbbVie Stock Like There's No Tomo... Source: Prosper Junior Bakiny

Jul 14, 2026 @ 10:55 PM Halper Sadeh LLC is Investigating Whether NEE, CRB... Source: Halper Sadeh Llc

Jul 12, 2026 @ 5:33 PM What This Apogee Insider Move Might Mean After a 2... Source: Jonathan Ponciano

Jul 12, 2026 @ 12:15 AM AbbVie Is Already a Dividend King. Here's Why the ... Source: Reuben Gregg Brewer

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-1.14	$-1.06	$-1.03
Diluted EPS	$-1.14	$-1.06	$-1.03
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-85.85M	$-74.11M	$-69.39M
Operating Income / Loss	$-96M	$-82.77M	$-78.06M
Cost of Revenue
Net Cash Flow	$-346.23M	$320.25M	$23.64M
PE Ratio